Can we pass from the experimental to the clinical phase in MS stem cell research?HOMMES, O. R.Journal of the neurological sciences. 2008, Vol 265, Num 1-2, pp 136-139, issn 0022-510X, 4 p.Conference Paper

Treatment Targets in Multiple Sclerosis: The Ends and the Means European Charcot Foundation SymposiumHOMMES, O. R; FRIEDRICHS, M.Journal of the neurological sciences. 2008, Vol 274, Num 1-2, issn 0022-510X, 87 p.Conference Proceedings

Clinical practice of immunosuppressive treatments in multiple sclerosis: results of a second international questionnaireHOMMES, O. R; WEINER, H. L.Journal of the neurological sciences. 2004, Vol 223, Num 1, pp 65-67, issn 0022-510X, 3 p.Conference Paper

Mending the brain: Stem cells and repair in multiple sclerosisHOMMES, O. R; FRIEDRICHS, M.Journal of the neurological sciences. 2008, Vol 265, Num 1-2, issn 0022-510X, 143 p.Conference Proceedings

New targets for treatment of multiple sclerosisSTEINMAN, Lawrence.Journal of the neurological sciences. 2008, Vol 274, Num 1-2, pp 1-4, issn 0022-510X, 4 p.Conference Paper

Treatment strategies in multiple sclerosis: From pathophysiology to clinical practiceHOMMES, O. R; FRIEDRICHS, M.Journal of the neurological sciences. 2007, Vol 259, Num 1-2, issn 0022-510X, 137 p.Conference Proceedings

Cognitive decline in multiple sclerosis: biological, clinical and therapeutics aspectsHOMMES, O. R; BOSMANS, M. Friedrichs.Journal of the neurological sciences. 2006, Vol 245, Num 1-2, issn 0022-510X, 214 p.Conference Proceedings

The effects of natalizumab on the innate and adaptive immune system in the central nervous systemSTÜVE, Olaf.Journal of the neurological sciences. 2008, Vol 274, Num 1-2, pp 39-41, issn 0022-510X, 3 p.Conference Paper

A Reappraisal of Nutrition and Environment in Multiple SclerosisHOMMES, O. R; FRIEDRICHS, M.Journal of the neurological sciences. 2011, Vol 311, Num 1-2, issn 0022-510X, 110 p.Conference Proceedings

Sodium channel blockers and neuroprotection in multiple sclerosis using lamotrigineKAPOOR, Raju.Journal of the neurological sciences. 2008, Vol 274, Num 1-2, pp 54-56, issn 0022-510X, 3 p.Conference Paper

Immunosuppressive treatments in multiple slerosisHOMMES, O. R; BOSMANS, M. Friedrichs.Journal of the neurological sciences. 2004, Vol 223, Num 1, issn 0022-510X, 96 p.Conference Proceedings

Results of an international questionnaire on immunosuppressive treatment of multiple sclerosisHOMMES, O. R; WEINER, H. L.Multiple sclerosis. 2002, Vol 8, Num 2, pp 139-141, issn 1352-4585Article

Immune cell entry into the central nervous system : Involvement of adhesion molecules and chemokinesENGELHARDT, Britta.Journal of the neurological sciences. 2008, Vol 274, Num 1-2, pp 23-26, issn 0022-510X, 4 p.Conference Paper

Preserve the neuron. Brain atrophy, axonal loss, remyelination and stem cells in MSHOMMES, O. R; BOSMANS, M. Friedrichs.Journal of the neurological sciences. 2005, Vol 233, Num 1-2, issn 0022-510X, 212 p.Conference Proceedings

Mechanisms of inflammation induced tissue injury in multiple sclerosisLASSMANN, Hans.Journal of the neurological sciences. 2008, Vol 274, Num 1-2, pp 45-47, issn 0022-510X, 3 p.Conference Paper

Neurodegeneration in multiple sclerosis : The role of oxidative stress and excitotoxicityGONSETTE, R. E.Journal of the neurological sciences. 2008, Vol 274, Num 1-2, pp 48-53, issn 0022-510X, 6 p.Conference Paper

The progressive phase of multiple sclerosis: pathology and treatmentHOMMES, O. R; BOSMANS, M. Friedrichs.Journal of the neurological sciences. 2003, Vol 206, Num 2, issn 0022-510X, 96 p.Conference Proceedings

T-cell subsets in spinal fluid of multiple sclerosis patientsHOMMES, O. R; BRINKMAN, C. J. J.Journal of neuroimmunology. 1984, Vol 6, Num 2, pp 123-130, issn 0165-5728Article

Autoimmunity in neuromyelitis optica and opticospinal multiple sclerosis: Astrocytopathy as a common denominator in demyelinating disordersKIRA, Jun-Ichi.Journal of the neurological sciences. 2011, Vol 311, Num 1-2, pp 69-77, issn 0022-510X, 9 p.Conference Paper

Vitamin D: Evidence for its role as a prognostic factor in multiple sclerosisMOWRY, Ellen M.Journal of the neurological sciences. 2011, Vol 311, Num 1-2, pp 19-22, issn 0022-510X, 4 p.Conference Paper

Expanding autologous multipotent mesenchymal bone marrow stromal cellsBRINCHMANN, Jan E.Journal of the neurological sciences. 2008, Vol 265, Num 1-2, pp 127-130, issn 0022-510X, 4 p.Conference Paper

Approved drugs and their problems in patient care : Routes of administration and dosingCOOK, Stuart D.Journal of the neurological sciences. 2007, Vol 259, Num 1-2, pp 38-41, issn 0022-510X, 4 p.Conference Paper

NG2-positive cells in CNS function and the pathological role of antibodies against NG2 in demyelinating diseasesTROTTER, Jacqueline.Journal of the neurological sciences. 2005, Vol 233, Num 1-2, pp 37-42, issn 0022-510X, 6 p.Conference Paper

A review of the health consequences of the vitamin D deficiency pandemicDOBNIG, Harald.Journal of the neurological sciences. 2011, Vol 311, Num 1-2, pp 15-18, issn 0022-510X, 4 p.Conference Paper

Immunosuppression : Promises and failuresOGER, Joël.Journal of the neurological sciences. 2007, Vol 259, Num 1-2, pp 74-78, issn 0022-510X, 5 p.Conference Paper